P. Grossman

发表

VEGF and IGF Delivered from Alginate Hydrogels Promote Stable Perfusion Recovery in Ischemic Hind Limbs of Aged Mice and Young Rabbits

D. Mooney, Erin M. Anderson, E. Doherty, 2017, Journal of Vascular Research.

Missed Opportunities to Treat Atherosclerosis in Patients Undergoing Peripheral Vascular Interventions: Insights From the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2)

K. Eagle, D. Mukherjee, M. Moscucci, 2002, Circulation.

Sustained Release of Multiple Growth Factors from Injectable Polymeric System as a Novel Therapeutic Approach Towards Angiogenesis

David J. Mooney, Qinghua Sun, Mitchell B. Schaffler, 2009, Pharmaceutical Research.

1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses.

D. Adams, H. Dauerman, T. Bajwa, 2017, JACC. Cardiovascular interventions.

Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis.

P. Grossman, Erinn K Hughes, 2021, Interventional cardiology clinics.

Cardiac-specific norepinephrine mass transport and its relationship to left ventricular size and systolic performance.

H. Oral, M. Starling, R. Mehta, 2004, American journal of physiology. Heart and circulatory physiology.

Expanding opportunities to understand quality and outcomes of peripheral vascular interventions: The ACC NCDR PVI Registry.

M. Jaff, E. Secemsky, E. Armstrong, 2019, American heart journal.

Contemporary outcomes with percutaneous vascular interventions for peripheral critical limb ischemia in those with and without poly-vascular disease

Katherine A. Gallagher, H. Gurm, P. Grossman, 2014, Vascular medicine.

Management of chronic critical limb ischemia.

S. Rajagopalan, P. Grossman, 2002, Cardiology clinics.

3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement.

J. Coselli, D. Adams, G. Deeb, 2016, Journal of the American College of Cardiology.

The Association of Peri-Procedural Blood Transfusion with Morbidity and Mortality in Patients Undergoing Percutaneous Lower Extremity Vascular Interventions: Insights from BMC2 VIC

H. Gurm, P. Grossman, P. Henke, 2016, PloS one.

Relation of systemic sympathetic nervous system activation to echocardiographic left ventricular size and performance and its implications in patients with mitral regurgitation.

M. J. Smith, H. Oral, M. Starling, 2000, The American journal of cardiology.

Defining the Optimal Degree of Heparin Anticoagulation for Peripheral Vascular Interventions: Insight From a Large, Regional, Multicenter Registry

H. Gurm, M. Moscucci, P. Grossman, 2010, Circulation. Cardiovascular interventions.

Improving Outcomes of Percutaneous Coronary Intervention through the Application of Guidelines and Benchmarking: Reduction of Major Bleeding and Blood Transfusion as a Model

E. Kline-Rogers, C. Montoye, M. Moscucci, 2007, Clinical cardiology.

A Comparison of Abciximab and Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Primary Percutaneous Coronary Intervention: A Meta-Analysis of Contemporary Randomized Controlled Trials

H. Gurm, E. Bates, P. Grossman, 2009, Circulation. Cardiovascular interventions.

Variation in Outcomes after Percutaneous Coronary Intervention in the United States and Predictors of Periprocedural Mortality

John A. Cowan, S. Rajagopalan, J. Dimick, 2005, Cardiology.

Management of intermittent claudication.

R. Brook, S. Rajagopalan, A. Weder, 2002, Cardiology clinics.

Impact of Annular Size on Outcomes After Surgical or Transcatheter Aortic Valve Replacement.

G. Deeb, J. Popma, N. Kleiman, 2018, The Annals of thoracic surgery.

Phase I study of multi-gene cell therapy in patients with peripheral artery disease

R. Wilensky, E. Mohler, B. Levine, 2012, Vascular medicine.

Safety of contemporary percutaneous peripheral arterial interventions in the elderly insights from the BMC2 PVI (Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention) registry.

H. Gurm, A. Riba, P. Grossman, 2011, JACC. Cardiovascular interventions.

Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials.

H. Gurm, P. Grossman, P. Henke, 2008, European heart journal.

Renal Function–Based Contrast Threshold Predicts Kidney Injury in Transcatheter Aortic Valve Replacement

W. O’Neill, H. Gurm, Sarah K. Gualano, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

The Quality and Impact of Risk Factor Control in Patients With Stable Claudication Presenting for Peripheral Vascular Interventions

H. Gurm, S. Kaufman, P. Grossman, 2012, Circulation. Cardiovascular interventions.

Contrast‐induced nephropathy in patients undergoing endovascular peripheral vascular intervention: Incidence, risk factors, and outcomes as observed in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium

H. Gurm, P. Grossman, H. Aronow, 2017, Journal of interventional cardiology.

Ankle-brachial index as a clinical tool.

P. Grossman, M. Ghannam, Yasser Rodriguez, 2012, The American journal of medicine.

Psoas muscle size as a frailty measure for open and transcatheter aortic valve replacement.

David C. Cron, G. Deeb, M. Englesbe, 2016, The Journal of thoracic and cardiovascular surgery.

Percutaneous coronary intervention complications and guide catheter size: bigger is not better.

H. Gurm, Thomas A Lalonde, M. Moscucci, 2009, JACC. Cardiovascular interventions.

Myocardial Proinflammatory Cytokine Expression and Left Ventricular Remodeling in Patients With Chronic Mitral Regurgitation

S. Bolling, H. Oral, D. Mann, 2003, Circulation.

Changes in systemic sympathetic nervous system activity after mitral valve surgery and their relationship to changes in left ventricular size and systolic performance in patients with mitral regurgitation.

H. Oral, M. Starling, K. Briesmiester, 2004, American heart journal.

Screening for Myocardial Infarction and Ischemic Stroke

K. Eagle, L. Lisabeth, Devin L. Brown, 2007, Neuroepidemiology.

Surgical Explantation of Transcatheter Aortic Valve Bioprostheses: A Statewide Experience

Melissa J. Clark, G. Deeb, P. Grossman, 2021 .

Surgical Explantation of Transcatheter Aortic Valve Bioprostheses

Melissa J. Clark, G. Deeb, P. Grossman, 2021, Circulation. Cardiovascular interventions.

Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Low-Gradient Aortic Stenosis.

H. Dauerman, G. Deeb, J. Oh, 2019, JACC. Cardiovascular imaging.

Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for Acute ST elevation MI: A Meta-Analysis of Randomized Controlled Trials

H. Gurm, I. Hameed, M. Moscucci, 2010, BMC cardiovascular disorders.

Prognostic implication of troponin I elevation after percutaneous coronary intervention.

B. Nallamothu, E. Kline-Rogers, D. Mukherjee, 2003, The American journal of cardiology.

Early Structural Valve Degeneration of Trifecta Bioprosthesis.

S. Bolling, Bo Yang, G. Deeb, 2020, Annals of Thoracic Surgery.

Coronary artery perforations after contemporary percutaneous coronary interventions: Evaluation of incidence, risk factors, outcomes, and predictors of mortality

Jacqueline L. Green, H. Gurm, S. Dixon, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Multifaceted Intervention to Improve P2Y12 Inhibitor Adherence After Percutaneous Coronary Intervention: A Stepped Wedge Trial

Marina S McCreight, G. Grunwald, H. Jneid, 2022, Journal of the American Heart Association.

Outcomes of Veterans Undergoing TAVR Within Veterans Affairs Medical Centers: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

E. Tseng, S. Garcia, H. Jneid, 2019, JACC. Cardiovascular interventions.

Usefulness of translesional pressure gradient and pharmacological provocation for the assessment of intermediate renal artery disease

Noah J. Jones, R. Lederman, E. Bates, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Compared with control subjects, the systemic sympathetic nervous system is activated in patients with mitral regurgitation.

H. Oral, M. Starling, R. Mehta, 2003, American heart journal.

The association of perioperative transfusion with 30-day morbidity and mortality in patients undergoing major vascular surgery.

H. Gurm, P. Grossman, P. Henke, 2015, Journal of vascular surgery.

Outcomes in Patients with Electrocardiographic Left Ventricular Dyssynchrony following Transcatheter Aortic Valve Replacement.

H. J. Patel, R. Latchamsetty, K. Jongnarangsin, 2022, Heart rhythm.

Basic Investigation Incomplete Retention After Direct Myocardial Injection

R. Lederman, P. Grossman, J. Barry, 2002 .

Impact of extracardiac vascular disease on acute prognosis in patients who undergo percutaneous coronary interventions (data from the Blue Cross & Blue Shield of Michigan Cardiovascular Consortium [BMC2]).

K. Eagle, B. Nallamothu, A. Defranco, 2003, The American journal of cardiology.

The initial U.S. experience with the Tempo active fixation temporary pacing lead in structural heart interventions

T. Nazif, M. Leon, S. Kapadia, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis.

H. Gurm, B. Nallamothu, C. Duvernoy, 2008, American heart journal.

Early Outcomes following Endovascular, Open Surgical, and Hybrid Revascularization for Lower Extremity Acute Limb Ischemia.

Katherine A. Gallagher, H. Gurm, P. Grossman, 2018, Annals of vascular surgery.

Long-term prognostic implication of extracardiac vascular disease in patients undergoing percutaneous coronary intervention.

K. Eagle, B. Nallamothu, E. Kline-Rogers, 2003, The American journal of cardiology.

Complication rates for percutaneous lower extremity arterial antegrade access.

P. Grossman, R. Cuff, M. Mansour, 2011, Archives of surgery.

The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

H. Gurm, S. Dixon, M. Moscucci, 2012, American heart journal.

Cardiovascular flashlight. Percutaneous treatment of a giant right coronary artery pseudoaneurysm in Adamantiades-Behcet's syndrome.

P. Grossman, S. Chetcuti, Christos Kasapis, 2009, European heart journal.

Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus.

P. Chan, H. Gurm, B. Nallamothu, 2007, The American journal of cardiology.

Improving anti-platelet therapy adherence in the Veterans Health Administration: A randomized multi-site hybrid effectiveness-implementation study protocol.

Marina S McCreight, G. Grunwald, M. Gillette, 2019, Contemporary clinical trials.

Development of a multicenter peripheral arterial interventional database: the PVD-QI2.

Sanjay Rajagopalan, Brahmajee K Nallamothu, K. Eagle, 2005, American heart journal.

Cellular and molecular therapeutic modalities for arterial obstructive syndromes.

B. Lewis, P. Grossman, D. Staudacher, 2006, Pharmacology & therapeutics.

Use of a Constitutively Active Hypoxia-Inducible Factor-1&agr; Transgene as a Therapeutic Strategy in No-Option Critical Limb Ischemia Patients: Phase I Dose-Escalation Experience

S. Rajagopalan, J. Laird, P. Grossman, 2007, Circulation.

Impact of sex on morbidity and mortality rates after lower extremity interventions for peripheral arterial disease: observations from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

Katherine A. Gallagher, H. Gurm, E. Jackson, 2014, Journal of the American College of Cardiology.

Impact of Sex on Morbidity and Mortality Rates After Lower Extremity Interventions forPeripheral Arterial Disease

Katherine A. Gallagher, H. Gurm, E. Jackson, 2014 .

Sustained Vascular Endothelial Growth Factor Delivery Enhances Angiogenesis and Perfusion in Ischemic Hind Limb

S. Rajagopalan, D. Mooney, P. Grossman, 2005, Pharmaceutical Research.

Transpulmonary passage of Albunex as a marker of intracardiac hemodynamics and outcome in chronic congestive heart failure.

H. Oral, P. Grossman, V. Sachdev, 2000, American heart journal.

Heterogeneity of Ankle-Brachial Indices in Patients Undergoing Revascularization for Critical Limb Ischemia.

H. Gurm, P. Grossman, P. Henke, 2017, JACC. Cardiovascular interventions.

If not now, when? Prescription of evidence-based medical therapy prior to hospital discharge increases utilization at 6 months in patients with symptomatic peripheral artery disease

H. Gurm, P. Grossman, P. Henke, 2015, Vascular medicine.

Current medical management of stable coronary artery disease before and after elective percutaneous coronary intervention.

B. Pitt, H. Gurm, M. Moscucci, 2013, American heart journal.

Incomplete retention after direct myocardial injection

Robert J Lederman, R. Lederman, P. Grossman, 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Association of Anemia With Outcomes in Patients Undergoing Percutaneous Peripheral Vascular Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2 VIC).

H. Gurm, R. Mehta, Thomas A Lalonde, 2018, The Journal of invasive cardiology.

Annulus instead of LVOT diameter improves agreement between echocardiography effective orifice area and invasive aortic valve area.

G. Deeb, A. Booher, P. Grossman, 2014, JACC. Cardiovascular imaging.

Redo Surgical Aortic Valve Replacement After Prior Transcatheter Versus Surgical Aortic Valve Replacement.

G. Deeb, Sarah K. Gualano, R. Hawkins, 2023, JACC. Cardiovascular interventions.

The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

H. Gurm, E. Jackson, S. Dixon, 2011, American heart journal.

Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease.

S. Rajagopalan, J. Regensteiner, W. Hiatt, 2004, Human gene therapy.

Aortic valve reintervention in patients with failing transcatheter aortic bioprostheses: A statewide experience.

G. Deeb, P. Grossman, S. Chetcuti, 2021, The Journal of thoracic and cardiovascular surgery.